Page last updated: 2024-10-31

midazolam and Paranasal Sinus Diseases

midazolam has been researched along with Paranasal Sinus Diseases in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research Excerpts

ExcerptRelevanceReference
"The etiology of the acutely developed atelectasis was unclear."1.34Pulmonary atelectasis manifested after induction of anesthesia: a contribution of sinobronchial syndrome? ( Amagasa, S; Igarashi, A; Oda, S; Yokoo, N, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Igarashi, A1
Amagasa, S1
Oda, S1
Yokoo, N1

Other Studies

1 other study available for midazolam and Paranasal Sinus Diseases

ArticleYear
Pulmonary atelectasis manifested after induction of anesthesia: a contribution of sinobronchial syndrome?
    Journal of anesthesia, 2007, Volume: 21, Issue:1

    Topics: Adult; Airway Obstruction; Analgesics, Opioid; Anesthesia, General; Anesthetics, Intravenous; Blood

2007